Trials / Completed
CompletedNCT01704196
A Multi-Center Trial of Nepicastat for Cocaine Dependence
Phase 2, Double-Blind, Placebo-Controlled, Parallel Group, Multi-Center Trial of Nepicastat for Cocaine Dependence
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 179 (actual)
- Sponsor
- National Institute on Drug Abuse (NIDA) · NIH
- Sex
- All
- Age
- 18 Years – 99 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to evaluate the safety and efficacy of Nepicastat in improving the number of subjects that achieve abstinence from cocaine and reducing cocaine use in subjects with cocaine dependence.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Nepicastat | 120 mg of active drug and 100mg of riboflavin daily for 11 weeks or matching placebo containing 100mg of riboflavin daily for 11 weeks. |
| DRUG | Placebo |
Timeline
- Start date
- 2013-04-01
- Primary completion
- 2014-08-01
- Completion
- 2014-12-01
- First posted
- 2012-10-11
- Last updated
- 2017-05-18
- Results posted
- 2017-05-18
Locations
10 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01704196. Inclusion in this directory is not an endorsement.